DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Medtech (296)

Therapeutic Botulinum Toxin | Medtech 360 | Market Insights | Global

Therapeutic Botulinum Toxin | Medtech 360 | Market Insights | Global

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

The global therapeutic BTX market will grow strongly through 2027, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK, Japan and Australia across a 10-year period.


New indication approvals will be significant drivers in the therapeutic BTX market.

Which indications contribute the most to growth?

What regional differences exist regarding indication approvals?

What new indications have the largest market potential?

The global therapeutic markets are becoming more and more consolidated.

What are some key competitive strategies being employed to succeed in the market?

How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest growth globally.

What key drivers contribute to a market's relative size and growth?

What factors most significantly affect pricing within markets?

Emerging products could have a significant impact on the BTX market.

Will emerging products expand on or compete against the existing BTX market?

What are some potential competitive advantages emerging products might have?

How will alternative treatments impact the BTX market?

Table of contents

  • Global
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Global Therapeutic Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication (Procedures Only)
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • First-Mover Advantage
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Regulatory Environment
        • Mergers, Acquisitions, and Partnerships
        • Competition From Alternatives
        • Pricing Strategies and Purchasing Options
      • Market Developments
    • US Therapeutic Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • European Therapeutic Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Asia Pacific Therapeutic Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Regulatory Environment
        • Pricing Strategies and Purchasing Options
    • Appendix
      • Abbreviations
      • Bibliography

Already a Client? Log in to access this report.

  • Pub Date: November 2018
  • Author(s): Robert Cohen, BSc
  • Robert is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of aesthetic injectables and cosmetic threads. Robert holds an Honors Bachelor's degree in Immunology from McGill University.

Purchase Report

Recent reports:
You may also be interested in: